Arxada Disinfectants Are Effective Against the Monkeypox Virus

In response to the Monkeypox virus outbreak, the EPA recently initiated emerging viral pathogen (EVP) status for Monkeypox virus. Arxada offers a variety of disinfectant solutions effective against the Monkeypox virus registered in accordance with the EVP program. Arxada's solutions include RTU, wipes, and concentrates for both consumers and professional markets.

The EPA has published List Q, which states eligible products for making off-label claims against the Monkeypox virus. Arxada's regulatory team can provide the documents with guidance that follows the EPA requirements.

Arxada has a complete portfolio of approved formulations under the EPA’s Emerging Viral Pathogens Program:

• Nugen MB5A
• Nugen MB5N
• Nugen RCS
• Nugen R-82
• Nugen HWS
• Nugen Carbosan D
• Nugen Bardac 205M
• Nugen Disinfectant Wipes
• Nugen Disinfectant Wipes Plus
• Nugen Disinfectant Wipes Plus 2
• Nugen 2M Disinfectant Wipes
• Nugen Citric Guard Wipes
• Nugen NR Disinfectant Wipes,
• RTU, and Concentrate
• Nugen EHP Wipes and RTU
• Nugen EHP-TB RTU


Quat-based products are known to be effective against Monkeypox virus when used in accordance with the EPA’s emerging viral pathogens program.

For more information regarding the disinfectants for Emerging Viral Pathogens (EVPs): List Q, click here.

The World Health Organization (WHO) may declare Monkeypox a global health emergency, stirring criticism from leading African scientists who say it has been a crisis in their region for years. The deliberations and scrutiny of the WHO's response to the outbreak follows concerns over how the United Nations agency and governments worldwide handled covid-19 in early 2020. A “public health emergency of international concern” is WHO's highest level of alert. The agency does not declare pandemics, but it did start using the term to describe covid-19 in March 2020.

The US Centers for Disease Control is tracking multiple cases of Monkeypox. The CDC is urging US healthcare providers to be alert for patients who have rash illnesses. The CDC notes, however, that Monkeypox is rare and does not spread easily between people without close contact. For more information on Monkeypox transmission, click here.

For more information on Arxada’s EPA List Q approved products, email [email protected]